Pandey JRC, Vyas GN, Dutta EH, Shah SK, Patel HJ. A comprehensive review of biomarker-based therapies for hormone receptor-positive and HER2-low breast cancer: clinical pharmacists’ implications. Int J Basic Clin Pharmacol [Internet]. 2026 Apr. 22 [cited 2026 Apr. 23];15(3):589-93. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/6271